ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Part of paid clinical trials in Sacramento, California.
- Sponsor
- Acurx Pharmaceuticals Inc.
- Study ID
- NCT07513285
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Clostridium Difficile Infection Recurrence
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ibezapolstat — DRUGIbezapolstat 450 mg po Q12H x14 days
Study Details
Single-arm trial to evaluate the safety and efficacy of ACX-362E \[ibezapolstat\] in patients with recurrent C. difficile infection (CDI).
Key Dates
- First listed
- Apr 7, 2026
- Start date
- Aug 6, 2026
- Status verified
- Aug 2026
- Primary completion
- Sep 29, 2027
- Completion
- Nov 24, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: IbezapolstatActive investigational antibacterial agent
Primary Outcome Measure
Evaluate the rate of CDI Clinical Cure (CC) [ Time Frame: Day 16 ]
Central Contacts
- Dee Rodriguez7742665290
Locations (15)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UC Davis Medical Center | Sacramento | California | 95817 | - |
| Gastroenterolgy Center of Conneticut | Hamden | Connecticut | 06518 | - |
| Florida International Medical Research | Coral Gables | Florida | 33134 | - |
| L&A Morales Healthcare, Inc | Hialeah | Florida | 33012 | - |
| San Marcus Research Clinc, Inc | Miami Lakes | Florida | 33014 | - |
| Belis Delgado, MD PA | Miami Springs | Florida | 33166 | - |
| Infectious Disease Consultants of Georgia | Athens | Georgia | 30606 | - |
| Snake River Research PLLC | Idaho Falls | Idaho | 83404 | - |
| Endevour Health | Skokie | Illinois | 60077 | - |
| Newton-Wellesley Hospital | Newton | Massachusetts | 02462 | - |
| University of Massachusetts Memorial Healthcare | Worcester | Massachusetts | 01655 | - |
| Henry Ford Hospital | Detroit | Michigan | 48202 | - |
| DiGiovanna Institute for Medical Education and Research | Massapequa | New York | 11758 | - |
| Romano, Pontzer & Associated | Pittsburgh | Pennsylvania | 15215 | - |
| University of Utah | Salt Lake City | Utah | 84115 | - |
Find similar trials in Sacramento, CA
Related Studies
- Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium DifficileRecruiting · Krunal Patel · Worcester, Massachusetts
- VE303 for Prevention of Recurrent Clostridioides Difficile InfectionPHASE3 · Recruiting · Vedanta Biosciences, Inc. · Huntsville, Alabama